Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay
Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of Proprietary Laboratory Analyses (PLA) code 0249U – originally issued to Theralink ...
Ignite Proteomics complete acquisition of PLA code 0249U
Ignite Proteomics, a subsidiary of IMAC Holdings (BACK), announced the completed transfer of Proprietary Laboratory Analyses, or PLA, code ...
Nasdaq3d
Ignite Proteomics LLC Completes Transfer of PLA Code 0249U to Enhance Breast Cancer Diagnostic Capabilities
Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc., has successfully transferred the Proprietary Laboratory Analyses (PLA) code 0249U from Theralink Technologies, allowing recognition and ...
Business Insider3d
Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay
Golden, CO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of Proprietary Laboratory Analyses ( ...
Mena FN3d
Ignite Proteomics Completes Acquisition Of PLA Code 0249U For Its Advanced Proteomic Breast Cancer Assay
(MENAFN- GlobeNewsWire - Nasdaq) Golden, CO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of ...
Nasdaq3d
Ignite Proteomics Completes Acquisition Of PLA Code 0249U For Proteomic Breast Cancer Assay
(RTTNews) - Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (BACK), on Wednesday announced the successful acquisition of Proprietary Laboratory Analysis or PLA code 0249U, initially ...